Reuters logo
BRIEF-GlaxoSmithKline announces unanimous FDA approval for Shingrix in over 50s
September 14, 2017 / 6:19 AM / 6 days ago

BRIEF-GlaxoSmithKline announces unanimous FDA approval for Shingrix in over 50s

Sept 14 (Reuters) - GLAXOSMITHKLINE PLC:

* UNANIMOUS FDA APPROVAL FOR SHINGRIX IN OVER 50S

* FDA ADVISORY COMMITTEE VOTES UNANIMOUSLY FOR SHINGRIX (HZ/SU) IN US FOR PREVENTION OF HERPES ZOSTER (SHINGLES) IN ADULTS AGES 50 AND OVER​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below